BRINZOLAMIDE Pharmacologic Class Indexing

Class set ID
6857d010-ffe0-441a-830b-5c16eaafe351
Version
2
Effective date
20180813
Type
Indexing - Pharmacologic Class

Mapped DailyMed Labels#

Label, Manufacturer, Effective table
LabelManufacturerEffectiveSPL version
These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 1998Oceanside Pharmaceuticals. | Bausch & Lomb202604202
BrinzolamideGranules India Limited202510248
These highlights do not include all the information needed to use SIMBRINZA ® safely and effectively. See full prescribing information for SIMBRINZA. SIMBRINZA ® (brinzolamide and brimonidine tartrate ophthalmic suspension) 1%/0.2%, for topical ophthalmic use Initial U.S. Approval: 2013Alcon Laboratories, Inc. | Alcon Research, LLC | S.A. Alcon-Couvreur N.V.2025031119
These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 1998Padagis US LLC202408314
These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 1998Bausch & Lomb Incorporated202407107
These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 1998Bryant Ranch Prepack20231219100
These highlights do not include all the information needed to use AZOPT safely and effectively. See full prescribing information for AZOPT. AZOPT ® (brinzolamide ophthalmic suspension) 1%, for topical ophthalmic use Initial U.S. Approval: 1998Sandoz Inc202311241
These highlights do not include all the information needed to use BRINZOLAMIDE OPHTHALMIC SUSPENSION safely and effectively. See full prescribing information for BRINZOLAMIDE OPHTHALMIC SUSPENSION. BRINZOLAMIDE ophthalmic suspension 1%, for topical ophthalmic use Initial U.S. Approval: 1998Sandoz Inc202306304